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Abstract. A  rat brain synaptosomal protein of 110,000 
Mr present in a fraction highly enriched in adenylyl cy- 
clase activity was microsequenced (Castets, F., G. Bail- 
lat, S. Mirzoeva, K. Mabrouk, J. Garin, J. d'Alayer, and 
A. Monneron. 1994. Biochemistry. 33:5063-5069). Pep- 
tide sequences were used to clone a cDNA encoding a 
novel, 780-amino acid protein named striatin. Striatin 
is a member of the WD-repeat family (Neer, E.J., C.J. 
Schmidt, R. Nambudripad, and T.F. Smith. 1994. Na- 
ture (Lond.). 371:297-300), the first one known to bind 
calmodulin (CAM) in the presence of Ca + ÷. Subcellular 
fractionation shows that striatin is a membrane-associ- 
ated, Lubrol-soluble protein. As analyzed by Northern 
blots, in situ hybridization, and immunocytochemistry, 
striatin is localized in the central nervous system, where 
it is confined to a subset of neurons, many of which are 
associated with the motor system. In particular, striatin 
is conspicuous in the dorsal part of the striatum, as well 
as in motoneurons. Furthermore, striatin is essentially 
found in dendrites, but not in axons, and is most abun- 
dant in dendritic spines. We propose that striatin inter- 
acts, through its WD-repeat domain and in a CaM/ 
Ca +  +-dependent manner, with one or several members 
of a surrounding cluster of molecules engaged in a 
Ca + +-signaling pathway specific to excitatory synapses. 
S 
YNAPSES are exquisitely organized subcellular struc- 
tures (5). In the presynaptic compartment, the stor- 
age  of neurotransmitters  in  vesicles, their release 
upon  Ca ++  influx, and  their reuptake involve a  host of 
proteins that include ion channels, enzymes, cytoskeletal 
elements,  regulatory  proteins,  and  transducers  (44).  In 
type I synapses, the postsynaptic compartment is charac- 
terized by the presence of a postsynaptic density (PSD),  1 a 
dense, filamentous structure linked to the inner face of the 
postsynaptic membrane (for review see 20). 
We have shown that mammalian brain synapses contain 
an adenylyl cyclase of unusually high specific activity (31). 
This has led us to speculate that either synapses contain an 
as yet unknown type of adenylyl cyclase, or that they are 
endowed with novel types of transducers or supramolecu- 
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lar  complexes particularly efficient in  the  channeling of 
stimulatory signals to adenylyl cyclase. To test these possi- 
bilities,  we  have  characterized  some  of  the  proteins 
present in synaptosomal preparations enriched in adenylyl 
cyclase. Among them, a protein of 110,000 Mr yielded, by 
proteolytic  digestion,  peptides  of  unknown  sequences. 
This study reports the cloning of the corresponding cDNA 
that encodes a  novel protein, striatin, shown to directly 
bind calmodulin in a Ca++-dependent manner. A member 
of the WD-repeat family of proteins (29), striatin is  the 
first  member  of this  family known  to  bind  calmodulin. 
Subcellular fractionation studies indicate that striatin is a 
membrane-associated, Lubrol-soluble protein. 
Striatin is shown here to be exclusively expressed in the 
central nervous system (CNS), principally in the neurons 
of the motor system: layer V of the sensory motor cortex, 
brain motor nuclei, especially the dorsal part of the cau- 
date nucleus, and motoneurons, but also in the olfactory 
tubercle as well as, to a lesser extent, in the hippocampus. 
This striking distribution goes together with a mostly den- 
dritic subcellular localization, especially dendritic spines, 
at the exclusion of axons. Striatin is therefore likely to en- 
gage in multiple protein interactions in a  Ca++-signaling 
pathway specific to postsynaptic compartments of a  de- 
fined subset of CNS neurons. 
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Obtaining of  Peptides and Microsequencing 
Pooled fractions enriched in rat CNS synaptosomal adenylyl cyclase (elu- 
ates from forskolin and calmodulin-affinity chiomatographics, referred to 
as FC fractions in reference 6) were subjected to PAGE (7.5% SDS--poly- 
acrylamide preparative gel). A  piece of gel containing 110 (+/-  5)-kD 
proteins was cut out and digested with 2 ~g/ml of endoproteinase Lys-C 
(Boehringer Mannheim GmBH, Mannheim, Germany) for 18 h at 30°C. 
The digested material was injected onto a DEAE column linked to a C 18 
reversed-phase HPLC column. Eluted peptides were sequenced on a gas- 
phase sequencer (470; Applied Biosystems, Foster City, CA). All 10 pep- 
tides sequenced (KxELTDIAIVLDNFK, KxVIDTSTIVRK,  KxWNPK, 
KMWNLQK, KxxIAEAGAxALAK, KDEPGAWEETF, KTLFGK, KPA- 
AVVLQTK, KNLFSYQEPK, and KVSLTLGMQxK) were not found in 
data banks. 
Amplification of DNA Using Reverse 
Transc  riptio  n-PC  R 
Total rat brain RNA was prepared by the urea-LiC1  method (3). mRNAs 
were purified on oligo(dT)-cellulose spin columns (Clontech, Palo Alto, 
CA).  Rat  brain  cDNAs were  obtained  by reverse transcription, using 
avian myeloblastosis virus reverse transcriptase and random hexanucle- 
otides according to the manufacturer's protocol (Amersham Intl., Little 
Chalfonet, England). Using the cDNAs as templates, PCR was achieved 
with degenerate oligonucleotide primers derived from the sequences of 
five of the peptides obtained from the protein of 110,000 Mr, in the pres- 
ence of Taq polymerase (Eurobio, Les Ulis, France). A  0.8-kbp DNA 
fragment  was  reproducively  obtained  using  the  sense  primer  corre- 
sponding to  the  sequence  IVLDNFK:  5'-ACGGATCCAT(A,C,T)GT 
(A,C,G,T)(CT)T  (A,C,G,T)GA(C,T)AA(C,T)TT(C,T)AA-3',  and  the 
antisense  primer  corresponding  to  peptide  KMWNLQ:  5'-GAGTC- 
GACTG(A,C,G,T)  A(A,G)(A,G)TTCCACAT(T,C)TT-3'.  Cycles were 
as follows: 3 rain, 94°C, 2 cycles with 1 min, 58°C, 2 min, 72°C, 1 min, 94°C; 2 
cycles with l min, 53°C, 2 min, 72°C, 1 min, 94°C; 40 cycles with 1 rain, 48°C, 
2 rain, 72°C, 1 rain, 94°C in a thermocycler (Bio Rad Laboratories, Irvine, CA). 
The 0.8-kb amplified DNA fragment was cloned in plasmid pUC18, yielding 
pUC18 FC used to generate a probe with which to screen a cDNA library. 
Cloning of the cDNA Encoding Striatin 
Among three rat brain cDNA libraries analyzed by PCR screening using a 
cDNA fragment obtained with oligonucleotides internal to the 0.8-kbp in- 
sert (5'-CAGTGATGAAGACGAGGATG-3'  and 5'-CCCTACTGAT- 
GTCCTGCTC-3'), one, constructed in X ZAP II (randomly primed; a gift 
of Dr. Marius Sudol, Rockefeller University, New York), was positive. Es- 
cherichia coil Y 1090 were infected with this library, and filter replicas (2 
×  106  phage  plaques)  were  hybridized  using  the  0.8-kbp  insert  from 
pUC18  FC,  radiolabeled  using  a  nick-translation  kit  and  [a32p]dCTP 
(Amersham Intl.). Replicas (Hybond-N+ membranes: Amersham Intl.) 
were hybridized at 42°C overnight in 5 × SSC, 1 × Denhardt's, 50% forma- 
mide, 20  ~xg/ml calf thymus DNA, and 0.3%  SDS. Filters were washed 
with 0.1× SSC, 0.1% SDS at 50°C. 14 plaque-purified phage were isolated 
with three rounds of screening (40).  In  vivo  excision of the plasmids, 
called pFC, was carried out using helper phage M13  K07.  The plasmid 
constructs were ordered relative to  each other by PCR  and restriction 
mapping; the inserts were sequenced and analyzed as described. 
DNA Sequencing 
Recombinant plasmids were purified by alkaline lysis (4) and sequenced. 
The inserts were sequenced on both strands by the dideoxy method of 
Sanger, according to Garoff and Ansorge (14), using T7 DNA polymerase 
(Pharmacia, Uppsala, Sweden) or Sequenase (United States Biochemical 
Corp., Cleveland, OH) and [a35S]dATP.  T3 and T7 primers (Pharmacia), 
as well as primers defined by the OLIGO program (37)  for the walking 
procedure, were used. Sequences were analyzed with the UWGCG pro- 
gram on a Silicon Graphics station (Mountain View, CA). The BLAST al- 
gorithm (2) was used for homology search on the GenBank data base. 
Construction of  Plasmids 
Construction of the Plasmid Encoding the Full-Length Striatin Sequence. 
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Figure 1.  Cloning of striatin cDNA and constructions of expres- 
sion  vectors.  (Solid  lines)  Striatin  cDNA  sequence.  (Boxes) 
Flanking plasmid sequences, pFC 5, 6, and 9 are three of the four- 
teen isolated pBluescript clones containing striatin inserts, pFCC 
is  a  full-length  clone  constructed  from pFC5  and  pFC9,  and 
pFCGN  is  constructed  from  pFCC  and  pFC6.  pFSVL  and 
pFDNA result from the insertion into pSVL and pcDNA 3 of the 
appropriate pFCC fragments, pFCX was obtained by digestion of 
pFCC. 
The 0.7-kbp KpnI-HpaI fragment of pFC5, which contains the 5' part of 
the coding sequence, was inserted into pFC9 previously deleted from its 
KpnI-HpaI fragment, yielding pFCC encoding striatin (Fig. 1). 
Construction of  Prokaryotic Expression Plasmids The pMF plasmid (Fig. 1) 
was constructed by inserting the first 150 bp of striatin cDNA into the 
BamHI and HindllI linearized plasmid pPLc 24, in frame with the coding 
sequence of the NH2-terminal portion (first 98 residues) of bacteriophage 
MS 2 polymerase (35). The 150-bp fragment was obtained by PCR using 
pFCC as template and  the  following oligonucleotides: 5'-ATGGATC- 
CCATGGACGAGCAGGCGGG-3'  and  5'-ATAAGCTTAAq~FAAT - 
TATGCAGGAAGTGCAAGATCCCC-3'.  pMF was used  to  overpro- 
duce a fusion protein containing the first 50 amino acids of striatiu, called 
fusion protein I (Fig. 2 B). The pFCGN plasmid was constructed by inser- 
tion of the Notl-HpaI fragment of pFCC into pFC 6 previously digested 
by the same enzymes, in frame with the sequence coding for the first 27 
amino acids of the a  fragment of 13-galactosidase  (Fig.  1). This plasmid 
was used to produce a hybrid protein containing the entire sequence of 
striatin, the so-called complete fusion protein, pFCX, used to generate a 
set of riboprobes (see below), was obtained by digesting pFCC with Xbal 
(Fig. 1). 
Construction of  Mammalian Expression Vectors. The  pFSVL  plasmid 
resulted from the insertion into XhoI-BamHI-digested pSVL (Pharma- 
cia) of the Xhol-BamHI fragment from pFCC (Fig.  1). 
DNA and RNA Blot Hybridization 
Southern blots of rat genomic DNA digested by EcoRl, HindIII, BamHl, 
and PstI were carried out as described (40), using a probe obtained by 
PCR, spanning sequence 1,293-2,316 (which contains an EcoRI site at bp 
1955), and labeled by random priming with [a32P]dCTP. mRNA from var- 
ious rat and mouse tissues was purified either from total  RNA using a 
Clontech kit, or from the tissues or cells (L1210  lymphocyte cell line) us- 
ing a messenger RNA isolation kit from Stratagene (La Iolla, CA). Ap- 
proximately 5  ~g of each mRNA were loaded on  1%  agarose and 6% 
formaldehyde gels, electrophoresed, and  transferred to  Hybond mem- 
branes by capillary transfer. The blots were hybridized with the appropri- 
ate radioactive probes as described (40). The probes consisted of several 
fragments of striatin cDNA, which together spanned the entire coding se- 
quence. They were prepared either by digestion of pFC  16 plasmid by 
HinclI, yielding a fragment corresponding to bp 668-1,647,  or by PCR, 
yielding DNA fragments corresponding to striatin sequences 1-720 (Fig. 2 B, 
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A 
-656 ATCTACTTAAGC  TTG~'TTAACTT  GGAATTCTACCAGTTGA/%GAGTATTT  GAATT  CCAC~d%AGCCRATAGCATGGAGAAG 
-577  T  CCCRAGATAACATGTCTTG  GGTRAGGGTAAGGAAACCCCGRACTTCCTCC TCCCT  CTAGGGCAAAACCTTCCCG  T  AAT 
-498 GC~C~CGGCCT~TGCC42TCT  C  CGACGTT  CCCCGGGATGAAGC~ACd2ATCGCTTGCC~ATA/~CAGGCGACAGGTCC  GAAG 
-419 AGGACT  C  CCGAGTT  CGGGAGTATCT  TTCCCTCGGGGCAGCCACGAT  TCCTCAAGCCC  CAGCGGCACCTCTCT  ATTAGCG 
-340 GCTCCT  TTGCCT  C~GTCGCCGACCGCT  GTCCCG~CGC~CCACCAGCAAC CACCCGC~CACGCTGAGGCCGCAGAC CGCA 
-261 AGTG  ACTCCCGGAGCCTGCTGAGTC TGCAGC~TCAGGTCCT  CGGGCCCCATTCGN~C  CCC~-aATC~%TGCTACCCGGTCAC 
-182 T  CTT  ACTGAATCTC  CCTATKTTTGT  CTACCTCCCAGAGTCTTT  CTCCTAGCATT  CAGC  CCT  GTGCAC  C  GAGATCCACT  C 
-103 AT  CCTCAAGATT  CTCTTTAGGGAGAGAAGCCGCAGAGATTC GGGGCTCGCT  CACCGTGC  TGGGCGCC  TAGGCAGAGCT  A 
-24 c  CCA  CGGGGTTTCGTGC  GGC  CGCC 
i ATG GAC GAG CAG GCG GGG CCC GGC GTC TTC TTC AGC A/%C AAC CAT CCG GGA C-CT GGC GGT 
M  D  E  Q  A  C  P  G  V  F  F  S  N  N  S  9  a  k  G  G 
61 GCT AAG GGG CTC GGG CCT CTG GCG GAG GCT GCA GCG GCG GGA GAC GGA GCG GCT GCG GCG 
21  A  K  G  L  G  P  L  A  E  A  A  A  A  G  D  G  A  A  A  A 
121 GGG GCG GCC CGA GCT CAG TAC AGC CTC CCG GGG ATC TTG CAC TTC CTG CAG CAC GA/% TGG 
41  G  A  A  R  A  Q  Y  S  L  P  G  I  L  H  F  L  Q  S  E  W 
181 GCC CGC TTC GAG GTG GAG AGA GCC CAG TGG GAG GTG GAG CGG GCG GAG TTG CAG GCT CAG 
241 ATT CCT TTC CTT CAG GGG GAG AGG A/M% GGC CAA GAA AAC TTG AAG AAA GAT CTT GTG AGG 
81  I  A  F  L  Q  G  E  R  K  G  Q  E  N  L  K  K  D  L  V  R 
301  AGG ATC AAA ATG TTG CAA TAT GCT CTG AAG CAG GAA AGA GCC ~J~ TAC CAC RAG TTG A/%A 
i01  R  I  K  M  L  E  Y  A  L  K  Q  E  R  A  K  Y  S  K  L  K 
361 TAT GGG ACA GAA CTG AAT CAG GGA GAC ATG AAG CCT CCA AGC TAT GAT TCT GAT GAA GGC 
121  Y  G  T  E  L  N  Q  G  D  M  K  P  P  S  Y  D  S  D  E  G 
421 AAT GAA ACG GAG GTG CAG CCA CAG CAG AAC AGC CAG TTC ATG TCG RAG CRA GGC CC43 CAG 
........  O  P  AQ  TQ  N  S  Q  ....  O  G  R  cQ 
481 CTC CTC AGA CAG TAT CTC CAG G  G  G  C  GGC TAC ACA GAT ACT ATT CTA GAT GTG RAG T  C 
161  L  L  R  Q  Y  L  Q  E  V  G  Y  T  D  T  I  L  P  V  K  S 
541 AAG CGT GTG CGG GCA TTG TTG GGC TTT TCA AGT GAT GTC ACT GAC AGG GAG GAT GAC A/%A 
181  K  R  V  R  A  L  L  G  F  S  S  D  V  T  D  R  E  D  D  K 
601 AAC CAG GAC TCG GTG ATA RAT GGC ACA GAG GCT GAA GTT A~  GAG ACA GCA ATG ATT GGA 
201  N  Q  D  S  V  I  N  G  T  E  A  E  V  K  E  T  A  M  I  G 
721  GCT GCA GAT TTC AGT GAT GAA GAC GAG GAT GAG GAC ATT GAT GGA AGA GAG ~  AGT GTC 
241  A  A  D  F  S  D  E  D  E  D  E  D  I  D  G  R  E  K  S  V 
781 A~T GA-T A~T TCA ACC ATT GTT AGG AAA AAA CCA TTA CCT GAT ACC AGT GAA~AT  ~GA GAC 
261  1  D  T  S  T  I  V  R  K  K  P  L  P  D  T  $  E  D  R  D 
841 ACA AAA G~  G~T C~G AAG GAG TT-T GA-C  TTC CTT GTC GCC TCA GAG GAP. GGA GAC SAC GAG 
281  T  K  E  A  5  K  E  F  D  F  L  V  ]%  S  E  E  G  D  N  E 
901 TCC AGA AGT CCA GGC GAC GGA ACG GAC TGG GAA A/%G GAA GAT CAG TGT CTG ACG CCG GAG 
301  S  R  S  A  G  S  G  T  D  W  E  K  E  D  Q  c  L  T  P  E 
961 CGC TGG AAT GTG GAC CAG GGA GTG ATC ACC AGA CTG AAG GAG CAG TAC A~  A/%G GAG AGG 
321  R  W  N  V  D  Q  G  V  I  T  R  L  K  E  Q  ¥  K  K  E  R 
1021 AAG GGG RAG AAA GGG GTG RAG AGG CCC AAT AGG TCA A~  CTA CRA GAT ATG CTT GCT A/%T 
341  K  G  K  K  G  V  K  R  P  N  R  S  K  L  Q  D  M  L  A  N 
1081 TTG AGA GAC GTT GAT GAA CTT CCC TCC TTG CAG CCA TCT GTT GGC TCC CCT TCC AGA CCC 
361  L  R  D  V  D  E  L  P  S  L  Q  P  S  V  G  S  P  S  R  P 
1141 ACC AGC TCC AGG CTT CCT GAG CAG GAC ATC AGT AGG GCA CAT GRA GTG GAA GCA TTG ACG 
381  S  S  S  R  L  P  E  Q  D  I  S  R  A  D  E  V  E  A  L  T 
1201 TTC CCG CCT TCT TCA GGG AAG TCA TTT ATC ATG GGA GCA GAT GRA GCC CTT GRA AGC GAG 
401  F  P  P  S  S  G  K  S  F  I  M  G  A  D  E  A  L  E  S  E 
1261 CTG GGG CTT GGA GAA TTA GCA GGC CTT ACA ~TG GCC AAT GAA GCA GAC TCA ~'~A GCT TAT 
421  L  G  L  G  E  L  A  G  L  T  V  A  N  E  A  D  S  L  A  Y 
1/21 GAT ATA GCG AAT AAC AAA GAC GCC TTG AGG AAG ACG TOG AAC CCT AAG TTT ACA TTA AGG 
441  D  I  A  N  N  K  D  A  L  R  K  T  W  N  P  K  F  T  L  R 
1381 AGT CAC TTT GAT GGC ATC CGA GCC CTT C~T ~TC C-AC C-CC  A-TC ~AG ~CT  GTG TTA ATA ACC 
461  S  H  F  D  G  I  R  A  L  A  F  H  P  I  E  P  V  L  I  T 
1441 GCG TCA GAG GAC CAC ACG CTG AAA ATG TGG AAT CTG CAG A~  ACA CCC CCA C~CT AAA AAG 
481  A  S  E  D  H  T  L  K  M  W  N  L  Q  K  T  A  P  A  K  K 
1501  AGT ACT TCT TTA GAT GTG GAG CCT ATC TAC ACC TTC AGG GCT CAC AAA GGT CCG GTG CTG 
501  S  T  S  L  D  V  E  P  I  Y  T  F  R  A  H  K  G  P  V  L 
1561 TGT GTG GTC ATG AGT AGC RAT GGT GAG CAG TGC TAC AGC GGC GGC ACT GAT GGC CTC ATC 
521  C  V  V  M  S  S  N  G  E  Q  c  Y  s  G  G  T  D  G  L  I 
1621 CAG AGC TGG AGC ACC ACC AAT CCC AAC GTC GAC CCC TAC GAT TCT TAT GAT CCT TCG GTT 
541  Q  s  w  s  T  T  N  P  N  V  D  P  Y  D  S  Y  D  P  S  V 
1681 CTA AGA GGC CCT CTG TTG GGC CAC ACG GAT GCG GTG TGG GGG CTG GCC TAC AGC GCG GCC 
561  L  R  G  P  L  L  G  H  T  D  A  V  W  G  L  A  ~  S  A  A 
1741 CAC CAG CGC TTG TTG TCC TGT TCA GCA GAC GGC ACT CTT CGT CTA TGG ACC ACC ACT GAG 
5SI  K  Q  R  L  L  S  C  S  a  D  a  T  L  R  L  W  T  T  T 
1801 GTT GCT CCA GCG CTG ACT GTA TTT AAT GAT AAC CAA GAA CTG GGA ATC CCT GCT TCT GTG 
601  V  A  P  A  L  T  V  F  N  [3  N  Q  E  L  G  I  P  A  S  V 
1861 GAT CTG GTG AGC AGT GAC CCG AGC CAT ATG GTA GCA TCG TTC AGC AAG GGA TAT ACA AGC 
621  D  L  V  S  S  D  P  S  S  M  V  A  S  F  S  K  G  Y  T  S 
1921 ATC TTC AAC ATG GAA ACA CAG CAG CGA ATT CTC ACG TTA GAA TCC AAT GTC GAT TCA ACG 
641  I  F  N  M  E  T  Q  Q  R  I  L  T  L  E  S  N  V  D  S  T 
1981 GCC AGT TCT TCC TGC CAA ATA AAC AGA GTC ATC AGT CAC CCC ACC CTC CCG ATC AGC ATC 
661  A  S  S  S  C  Q  I  N  R  V  I  S  H  P  T  L  P  I  S  I 
2041 ACT GCT CAC GAG GAC AGG CAC ATC AAG TTC TAC GAT AAC AAC ACA GGC A~  CTG ATC CAC 
681  T  A  H  E  D  R  H  l  K  F  Y  D  N  N  T  G  K  L  ~  H 
2~o~  Tc~  ~r~  ~s  c-cc  c~c  cz~  ~  c,  cc  ~'r~  ~c~  ~r  r~  GC~  G~  GAr  ccc  ,~ac  GGC  C~  ~c 
701  S  M  V  A  H  L  E  A  V  T  S  L  A  V  D  P  N  G  L  Y 
2161 CTG ATG TCT GGC AGT CAT GAC TGT TCA ATA CGC TTG TGG AAT TTA GAA AGT AAG ACG TGT 
721  L  M  S  G  S  H  D  C  S  I  R  L  W  N  L  E  S  K  T  C 
2221 ATC CAG GAG TTC ACA GCT CAT CGG A~  AAG TTT GAP, GAG TCG ATC CAT GAT GTA GCA TTC 
741  1  Q  E  F  T  A  8  R  K  K  F  E  E  S  I  H  D  V  A  F 
2281  CAC CCT TCT A~a% TGC TAT ATA GCC AGC GCT GGA GCC GAC GCC CTG GCT AAG GTC TTT GTA 
761  H  P  S  K  C  Y  I  A  S  A  G  A  D  A  L  A  K  V  F  V 
2341 TGA 
stop 
2344 TGGGGTACTTCAGCTTCACCCTGCAGCTCTTACAAGTC~ACCGCACACAGGAAACGGAAGACCAGGGCGGGAGCCAGCT 
2423 CGCCCTGCCCTTTTGTTTC43CTGAGGGAGCACAGAGACCTCTGTTA~GTACAGTTTTGCAGTTCCTATACAGTTTTCT 
2502 AAAATT~/%GGTTTGTTCAGGTTGCTCCAAGCTCAGCTGAACCTGTGAGCCCC~CTTTCAGATCCCCCCAAAGAGGCA 
2S81 CTTTTATTTCTGAGGTTGTTCTCACTCGCTAGGC~CCGAGCGTTCGTTCTCCCTTTTGAGTAAGCAGGGCATGCTG 
2660 TAATGGATAATTAGAGGTGAATGCCGGGAATGAGTAGAATGGA~TTT~ACTATCCTTCCACCCCGAGACATCTGCTAC 
2939 CACATAGGTAGTCAGCTCTGCGGCTGTGTGTGCTCTACTAACCCCACTGTGTAGAAGGAGACAGTGTGTGTCAGTGTTC 
2818 ACATGAGGTCCTCCCCCTGCTGTCCTCTCAGACCGTTCTCATGAAGCACAGGGAAGAGTGTTCCTTCCACCTGTAGGAG 
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Figure 2.  (A) Nucleotide and predicted amino acid sequences of 
the striatin cDNA. Nucleotides are positively numbered from the 
first base of the putative initiation codon, in the 5' to 3' direction; 
the nucleotides on the 5' side of residue 1 are indicated by nega- 
tive numbers. The amino acid sequence, in single-letter code, is 
shown below the nucleotide sequence. The sequences of the five 
peptides generated by digestion of the brain 110-kD protein are 
underlined. (B) Schematic representation of striatin ORF and its 
flanks. The single straight lines depict the 5' and 3' UTR regions 
of the cDNA; the protein coding sequence is shown as a box. The 
four dark rectangles indicate regions coding for highly charged 
peptides, two negatively charged (-), and one positively charged 
(+),  and  the  diagonally  striped  bars  correspond  to  the  WD- 
repeats,  numbered  1-8.  Below  the  model,  the  horizontal bars 
numbered I, II, and III indicate the amino acid sequences 1-50, 
contained in fusion protein I, 191-205, corresponding to peptide 
I1, and 267-287, corresponding to peptide III, respectively. Anti- 
bodies  have  been  obtained  against  these  peptides.  (Double- 
headed arrow) Nucleotide  sequence  1-750  corresponding  to 
probe 1, one of the probes used for Northern blots. (C) Compari- 
son of the amino acid sequences of the "WD-repeat" consensus 
defined  by  Neer  et  al.  (29)  (Fig.  2 C, upper) and  of  striatin 
(lower). These  sequence  data  are  available  from  EMBL/Gen- 
Bank/DDBJ under accession number X99326. 
double-headed arrow), 720-1,215,  1,293-2,316,  and 1,970-2,685.  The frag- 
ments were purified using a GeneClean kit (Bio  101, LaJolla, CA). 25 ng 
of each were radiolabeled (2 ×  10  ~ cpm/l~g DNA)  by random priming us- 
ing a  Stratagene  kit in  the presence  of [anP]dCTP.  An actin probe  (M. 
Buckingham, Institut Pasteur, Paris, France) was radiolabeled in the same 
way. After the hybridization step,  the blots  were washed  three times (20 
min each)  at 50°C  in  buffer L  (0.1×  SCC,  0.1%  SDS).  Autoradiograms 
(Fuji RX films and amplifying screens [Fuji Photo Film Co.,  Ltd., Tokyo, 
Japan]) were exposed at -80°C. 
In Situ Hybridization 
Four adult Wistar rats (200-250 g) were used. The animals were killed by 
decapitation,  and the brains were quickly removed, frozen on powdered 
dry ice, and stored  at -70°C.  Frontal and saginal sections  of 10 p.m were 
cut on a cryostat and thaw-mounted on subbed slides. In situ hybridization 
histochemistry  was  performed  as  described  (38).  Briefly,  sections  were 
fixed in formaldehyde, acetylated, dehydrated, and hybridized in a humid 
chamber at 50°C  for 3.5  h  with 3-5  ng of 35S-radiolabeled  RNA  probes 
complementary to (antisense) and similar to (sense)  striatin mRNA.  Sec- 
tions were then washed at 52°C in 50%  formamide and 2×  SSC and incu- 
bated with RNase A  (100 ixg/ml) in 2×  SSC at 37°C for 30 min. Sections 
were dehydrated, defatted, and apposed to films (X-OMAT AR; Eastman- 
Kodak Co., Rochester, NY) for 6-10 d. The 3~S-radiolabeled RNA probes 
were  obtained  as  follows:  pFC  10,  encoding  sequence  840-1,192,  and 
pFCX  (Fig.  1) were linearized and transcribed using T3 and T7 polymer- 
ases  (RNA  transcription  kit from Stratagene)  in the  presence of 50 i~Ci 
[3SS]UTPctS  (>1,000  Ci/mmol,  10 mCi/ml: Amersham Intl.) in a final vol- 
ume of 20 Ixl. 
Tissue and Cell Fractionation, Calmodulin-Sepharose 
Affinity Purification, Western Blots, and 
Immunoprecipitation 
Protein was determined by the method of Schaffner and Weissmann (41). 
Homogenates  of rat whole brain, striatum, hippocampus,  hypothalamus, 
cerebellum,  and  brain  cortex  were  heated  in  Laemmli  sample  buffer; 
equal amounts of protein were electrophoresed on 7.5%  SDS-PAGE  gels 
and blotted as described (31). Other types of PAGE  described by Neville 
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used. Fractions enriched in synaptosomes were prepared by flotation as 
described (25). Rat brain, striatum, or synaptosomes  were homogenized in 
ice-cold buffer B  (50 mM triethanolamine, pH 7.6,  5 mM MgCI2, 2 mM 
DTT, 0.3 M sucrose, inhibitors of proteases: 0.1mg/ml trypsin inhibitor, 
2 I~g/ml leupeptin, aprotinin, and pepstatin, 1 mM Pefabloc [Boehringer 
Mannheim GmBH], and then centrifuged at 100,000 g for 70 min at 4°C. 
The supernatants were saved, and the pellets were homogenized in the 
presence of 0.9% Lubrol-PX (Lubrol/protein ratio of 2.5) and centrifuged 
as described (10). The Lubrol-soluble fractions were incubated for 4 h at 
4°C with calmodulin (CaM)-Sepharose (~1 g resin per 10 p~g protein) in 
the presence of 1 mM Ca  ++, as described (9). The flow-through was saved. 
After several washes, the CaM-binding proteins were elated in a  1 mM 
EDTA- or EGTA-containing buffer and TCA precipitated (9). 
PSDs were prepared according to Cohen et al. (7). Fractions were ana- 
lyzed  by  Western  blots,  using preimmune and  immune sera  directed 
against fusion protein I and striatin peptides II and III (see below). Either 
the enhanced chemiluminescence (ECL) (Amersham Intl.) procedure, or 
the procedure using alkaline phosphatase-coupled anti-rabbit antibodies 
(Promega, Madison, WI) were applied. In other experiments, immunopre- 
cipitation studies were achieved as described (40), using Pansorbin (Calbi- 
ochem-Novabiochem Corp., La Jolla, CA) preincubated with the antibod- 
ies  described  below  (12  p.l  of  serum  for  50  p.1  of  a  10%  Pansorbin 
suspension). The samples to be studied were incubated with mild agitation 
at 4°C with the antibody-treated Pansorbin aliquots for 2 h. Adenylyl cy- 
clase activities were determined in the pellets and supernatants (31).  In 
parallel, both fractions were analyzed by SDS-PAGE and Western blots. 
Preparations highly enriched in synaptosomal adenylyl cyclase activity, 
called FC fractions (31), were incubated in the presence of various con- 
centrations of affinity-purified anti-peptide II or III antibodies; adenylyl 
cyclase activity was measured in basal condition, in the presence of 100 
p.M forskolin, various concentrations of Ca ++, or 1 ~M calmodulin +/- 
10 ~M Ca  ++ or +/-  1 mM EGTA as described (31). 
Expression of Striatin in E. coli Cells 
pMF was used to direct the synthesis of fusion protein I in E. coli SG 4044 
cells grown at 4I°C. The fusion protein was produced as inclusion bodies 
that were purified. They were dissolved in LSB sample buffer (4 M urea, 
25 mM Tris-HCl, pH 8.0,  10 mM EDTA, 50 mM DTT) and electrophor- 
esed on 15% SDS-polyacrylamide gels. The 18-kD protein band was sep- 
arated on a preparative SDS-polyacrylamide gel by reverse electrophore- 
sis  (24)  and  TCA  precipitated.  Scanned  Coomassie blue-stained  gels 
containing purified fusion protein I showed that it was at least 90% pure. 3 
mg fusion protein I was obtained from 1 liter of bacterial culture. 
pFCGN was used to infect E. coil cya-TP 610 (18) and TP 610 CaM cells 
(15), grown on Luria-Bertani broth and selected on Mac-Conkey-maltose 
medium. Induction of striatin synthesis was achieved by adding 15 v,g/ml 
isopropylthio-13-D-galactoside. The adenylyl cyclase activities of the con- 
trol and transformed lysed cells were determined. In other experiments, 
the soluble fraction of the lysate of pFCGN-transformed E. coil cells was 
complemented with 1 mM Ca  ++  and loaded on a  CaM-Sepharose col- 
umn, as described above. The flow-through was saved, and the resin was 
washed. The EDTA- or EGTA-eluate was collected, TCA precipitated, 
and analyzed by Western blotting. 
absence of 10 I.~M forskolin, with or without 1 txM isoproterenol, or with 
the Ca  *+ ionophore A  23187 (Sigma Chemical Co., St. Louis, MO). Nu- 
cleotides were extracted by adding 2.5% cold PCA to the dishes. Samples 
were neutralized and [3H]cAMP was measured, using [32P]cAMP  for cali- 
bration of the chromatographic columns. Untransformed and transformed 
(48 h) COS cells, grown in triplicate dishes for each condition, were lysed 
and assayed for protein and adenylyl cyclase activity (basal and forskolin- 
stimulated activities). 
Antibodies 
Three rabbits were immunized with the purified fusion protein I (150/~g 
per injection) according to published procedures. Titers were determined 
by ELISA, using bacterial soluble lysate containing the complete fusion 
protein as coating antigen. Titers were of the order of 1/10,000 after 4 mo. 
Peptides corresponding to striatin sequences 191-205 (peptide II) and 
267-287 (peptide III)  (Fig. 2 B) were synthesized with an NH2-terminal 
added cysteine (P.  Fourquet,  CIML,  CNRS,  Universit6 de la  Mrditer- 
ranre, Marseille, France). They were coupled to pig thyroglobulin (Sigma 
Chemical Co.) by means of sulfo-MBS (Pierce Chemical Co., Rockford, 
IL) according to described procedures (45).  Three rabbits were injected 
with peptide II, and two rabbits were injected with peptide III. Titers were 
determined by ELISA, using peptides coupled to ovalbumin by means of 
1-ethyl-3-[3-dimethylamino-propyl]carbodiimide  hydrochloride  (EDC) 
(Pierce Chemical Co.) as coating antigens. Specific anti-peptide antibod- 
ies were prepared by adsorbing sera on Sulfogel (Pierce Chemical Co.) 
coupled to each peptide (1 mg peptide per ml). Antibodies were eluted 
from the resin by adding a 10 mM glycine-HC1 buffer, pH 3.0; the eluates 
were extensively dialyzed and concentrated by centrifugation in a  Cen- 
triprep 30 (Amicon Corp., Danvers, MA). 
Iramunocytochemistry 
15 young male Sprague-Dawley rats (120-140 g) were deeply anesthetized 
and perfused transcardiacally with 300 ml of a cold 3% paraformaldehyde 
solution containing 0.08% glutaraldehyde. Coronal Vibratome sections of 
the striatum were collected in ice-cold PBS containing 50 mM NH4CI and 
cryoprotected before being permeabilized by three cycles of freeze-thaw- 
ing  in  liquid  nitrogen.  The  preembedding free-floating technique was 
used. Briefly, the blocked sections were soaked overnight in ice-cold solu- 
tions containing 1-3 Ixg/ml of affinity-purified antibodies directed against 
striatin peptides II and III (Fig. 1 B). Biotinylated goat anti-rabbit second 
antibody (Vector Laboratories, Burlingame, CA) was used at a dilution of 
1:100 and decorated with avidin-biotin-HRP complex (Vector Laborato- 
ries). The sections were postfixed with 2% glutaraldehyde, and the perox- 
idase complex was revealed with 0.05% 3.3'DAB tetrahydrochloride and 
0.033% H202, Sections were fixed in 1% OsO4, contrasted in 1% uranyl 
acetate, dehydrated, and flat-embedded in Durcupan (Fluka AG, Buchs, 
Switzerland). Ultrathin sections were observed without further staining on 
an electron microscope (CM 10; Philips Electronic Instruments, Mahwah, 
NJ).  A  few sections were processed for light microscopy just after the 
DAB reaction. Three purified anti-peptide antibodies raised against pep- 
tides I1 and III were used: two gave comparable immunocytochemical re- 
actions, and one gave no reaction and was used as a control. Other con- 
trois included (a) the omission of the primary antibodies, and (b) the use 
of primary antibodies adsorbed with their peptides added at a 100:1 molar 
ratio. 
Expression of Striatin in COS-I Cells 
COS-1 cells were cultured in DME (GIBCO  BRL, Gaithersburg, MD) 
containing 10% FCS, 4 mM glutamine, and antibiotics; they were trans- 
fected either by the DEAE-dextran procedure  (40) or by the liposome 
method (adapted from 36), using pSVL or pFSVL (5 Ixg per one 10-cm 
petri dish). Trypsinized COS-1 cells were centrifuged, and the pellets were 
lysed for 30 min on ice in lysis buffer (50 mM Tris-HCl pH 7.5,  t % Triton 
X-100, 50 mM NaCI, 25 mM NaF, 1 mM EDTA, and the above cited in- 
hibitors of proteases). The lysates were centrifuged twice  (20,000 g, 30 
rain, 4°C), and the supernatants were subjected to immunoprecipitation. 
Triplicate dishes of COS-1 cells, untransfected and transfected by pFSVL 
or pSVL, were incubated, 48 h  after transfection, in DME without FCS 
containing 2  ~Ci/ml of [83H]adenine (24 Ci/mmol; Amersham Intl.), ac- 
cording to the procedure described by Salomon (39). After several washes 
and a  10-min incubation in the presence of 0.1  mM isobutylmethylxan- 
thine (EGA-Chemie), they were incubated for 10 min in the presence or 
Results 
cDNA Cloning  of  Striatin and Analysis of  the Predicted, 
Encoded Protein Sequence 
A  110,000-Mr,  Lubrol-soluble protein present in an adeny- 
lyl cyclase-enriched synaptosomal fraction was obtained 
by PAGE and digested in the gel. 10 of the obtained pep- 
tides were sequenced and found to be original. Sense and 
antisense  degenerate oligonucleotides  deduced  from five 
of them  were  used  as  primers  in  reverse  transcription- 
PCR  reactions  with  cDNAs  obtained  by  reverse-tran- 
scribed  rat  brain  mRNAs  as  template.  A  novel 0.8-kbp 
DNA  fragment  was  obtained,  encoding  four  of the  se- 
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ZAP rat brain  cDNA library with  this  probe yielded  14 
overlapping clones,  defining  a  novel  3,635-bp  sequence. 
This sequence contains an open reading frame (ORF) of 
2,343  nucleotides (nt) flanked by a 656-nt-long 5' untrans- 
lated sequence (UTR) and a 636-nt-long 3' UTR (Fig. 2, A 
and B). The 3' untranslated  sequence does not contain a 
polyadenylation signal. The protein encoded by the ORF 
has been called  striatin  since,  as  shown below, it is pre- 
dominantly localized in the striatum. An ATG codon, pre- 
ceded by several stop codons, lies within a  canonical  eu- 
karyotic  translation  start  sequence  (22).  The  predicted 
protein sequence encodes 780 amino acids. It contains five 
of the  ten  peptides originating  from the  digestion  of the 
ll0,000-Mr  component. Thus, in  the  preparative gel, an- 
other synaptosomal protein migrates with an apparent rel- 
ative molecular mass identical to that of striatin. We have 
sequenced  the  latter protein, which  appears to be a  gly- 
cosidase (to be reported elsewhere). 
A  search for protein homologies in the NCBI data bank 
shows the presence, at the COOH-terminal end, of eight 
short sequences known as 13-repeats or WD units at posi- 
tions 419-454,  461-491,  514-544,  567-597,  613--643,  662- 
692, 704-734, and 746-780 (Fig. 2 B, numbered from 1 to 8); 
striatin is thus a member of the WD-repeat family (29). One 
WD-unit perfectly matches the consensus (repeat 2), and 
four contain three or fewer mismatches (repeats 4, 6, 7, 8); 
unit  1  (six mismatches), 3  (4  mismatches), and  5  (8 mis- 
matches) only loosely conform to the consensus (Fig. 2 C). 
Besides,  numerous  potential  phosphorylation  sites  are 
scattered over the sequence: 10 for calcium/phospholipid- 
dependent protein kinase C (serine or threonine 180,  194, 
382,  405,  458,  486,  511,  592,  695,  and  729)  and  18  for 
casein-kinases. Four highly charged short sequences, one 
bearing a net positive charge of 9 (331-353), and another 
bearing a net negative charge of 7 (246-258), are found in 
the  NH2-terminal region.  The  region  spanning  sequence 
87-104 is predicted to be an amphipatic a  helix having a 
positively charged side  and a  hydrophobic side.  Some of 
these structural elements are shown in Fig. 2 B. Analysis 
of the striatin protein sequence does not reveal hydropho- 
bic e~ helices suggestive of transmembrane segments. No 
known  ATP-  or  GTP-binding  consensus  sequences  are 
present. Striatin has a calculated isoelectric point of 5.16. 
While  our  study was  completed,  the  cDNA  of a  new 
member of the  WD-repeat family, coding for  a  shorter, 
713-amino  acid  human  nuclear  protein,  SG2NA,  of un- 
known function, was published (28). Its protein sequence 
is 80%  similar to and 66%  identical with sequences of a 
similar length from striatin, in both the NH2-terminal and 
the  WD-repeat COOH-terminal domains, but  not in  the 
central domain. Although Muro et al. (28) report six WD 
repeats in the SG2NA sequence, we indeed noticed in this 
sequence two more WD repeats, at positions 353-387 and 
679-713.  Having  now  obtained  the  human  striatin  se- 
quence (to be published elsewhere), we can state that stri- 
atin  and  SG2NA  are  different  proteins,  defining  a  new 
subfamily of WD-repeat proteins. 
Striatin Is a Detergent-soluble I l O, O00-Mr Protein 
To identify the product of the striatin gene, antisera were 
Figure 3.  Expression  of striatin, as analyzed by Western blots re- 
vealed by antibodies  directed  against fusion protein I (anti-pep- 
tide I), using phosphatase-coupled second  antibodies  (A, B, and 
C) or the ECL procedure (D). (A) Soluble fraction of the lysate 
of E. coli cells transformed by plasmid  pFCGN (lane  1; 40 ~g/ 
lane), adult rat brain homogenate (lane 2; 80 ixg/lane), and lysate 
of COS-1 cells transfected with plasmid  pFSVL (lane  3; 70 Ixg/ 
lane). Striatin migrates at the same position in SDS-PAGE, what- 
ever its origin. (B) Adult rat brain striatin binds to CaM-Sepharose 
in the presence of Ca  +  +. (Lane I) Brain Lubrol-soluble  proteins 
before loading on CaM-Sepharose (total protein:  4.5 mg; 48 Ixg/ 
lane  1); (lane 2) proteins in the flow-through  (total protein:  2.8 
mg; 48 ixg/lane 2); (lane  3) proteins in the EDTA-eluate (total 
protein: 150 txg; 18 ~g/lane 3). (C) The soluble fraction of the ly- 
sale  of  E.  coli  cells  transformed  by  plasmid  pFCGN  (total 
amount:  30 mg protein;  120 txg/lane 2) was incubated with CaM- 
Sepharose (3 ml); the flow-through  was collected  (18 mg protein; 
86  ixg/lane 1);  and  the  resin  was  washed  (10 mg protein;  not 
shown). EDTA-eluates were then collected (first 4 ml, 80 Ixg pro- 
tein; lane 3:40 ixg; next 4 ml, 10 Ixg, not shown). (D) Normalized 
amounts of homogenates of various rat brain regions were ana- 
lyzed by Western blot. (Lane 1) Hypothalamus; (lane 2) hippoc- 
ampus; (lane 3) cerebellum;  (lane 4) striatum; (lane 5) cerebral 
cortex. 
obtained.  Some were raised  against  a  fusion protein  ex- 
pressed in E. coli by plasmid pMF (Fig. 1), containing the 
first 50 amino acids of striatin (fusion protein I; Fig. 2 B); 
others were directed against two charged striatin peptides 
II (sequence 191-205) and III (sequence 267-287), located 
in the NH2-terminal region of the protein (Fig. 2 B). Im- 
munoblot studies carried out with each type of anti-striatin 
antibodies reveal the presence of only one 110,000-Mr pro- 
tein in rat brain and spinal cord homogenates as well as in 
synatosomal purified membrane fractions where this pro- 
tein  is  enriched  (Fig.  3,  A  and  B,  lanes 2  and  1,  respec- 
tively). Striatin has a theoretical molecular mass of 86,225. 
The apparent relative molecular mass of striatin deduced 
by PAGE is thus higher than predicted by 23,800.  When 
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(30) or gels containing either 6 M urea or an anionic deter- 
gent instead of SDS (32), it again has a  110,000 Mr, con- 
firming its anomalous electrophoretic behavior. Striatin is 
particulate, only ~  1% being found in the 100,000-g super- 
natant of rat brain homogenates or synaptosomes. Upon 
Lubrol solubilization of brain or synaptosomal pellets, stri- 
atin  mostly  partitions  in  the  Lubrol-soluble  fractions. 
When synaptosomes are resolved in a PSD fraction and a 
Lubrol-soluble fraction (7), striatin is essentially present in 
the Lubrol-soluble fraction. Even in striatal homogenates, 
the richest source of striatin, this protein occurs in very 
low  abundance,  not  being  revealed  by  Coomassie  blue 
even in overloaded gels. This fact is in agreement with the 
scarcity  of  the  110,000-Mr  synaptosomal  protein  from 
which we obtained peptides. 
Expression of Striatin in Heterologous Systems 
To confirm the identity of the brain  110,000-Mr  protein, 
we  compared its  electrophoretic behavior with  those  of 
the proteins expressed by striatin-encoding vectors in bac- 
teria and mammalian cells. E. coli cells transformed with 
the plasmid pFCGN (Fig. 1) express a soluble, 110,000-Mr 
fusion  protein  (expected  Mr:  89,200),  migrating  at  the 
same position in SDS-PAGE as brain striatin  (Fig. 3 A, 
lane  1).  This  is  in  favor of pFCGN  being  a  full-length 
clone.  It  also  follows  that  eukaryotic  posttranslational 
modifications are not likely to account for the anomalous 
behavior of striatin in SDS-PAGE. 
Mammalian COS-1 cells were transfected with plasmid 
pFSVL encoding striatin  (Fig.  1).  A  110,000-Mr  protein, 
migrating in SDS-PAGE at the same position as brain stri- 
atin, can readily be detected by anti-peptide antibodies II 
and III in Western blots of lysates or immunoprecipitates 
of the lysed cells (Fig. 3 A, lane 3). 
Striatin Directly and Quantitatively Binds Ca ÷  +-CaM 
Brain striatin quantitatively binds CaM-Sepharose in the 
presence of Ca ++  (Fig. 3 B, lanes 1 and 2), but not in its 
absence. It is eluted from the affinity-resin by EDTA- or 
EGTA-containing  buffers,  as  shown  by  Western  blots 
(Fig. 3 B, lane 3). 
The bacterially expressed fusion protein comprising the 
full-length striatin also quantitatively binds CaM-Sepharose 
in the presence of Ca ++ (Fig. 3 C, lanes 1 and 2), but not in 
its  absence,  and  is  eluted from the  resin  by EDTA-  or 
EGTA-containing buffer (Fig. 3 C, lane 3). Since calmodu- 
lin is not found in bacteria, and since bacterial proteins do 
not bind  CaM-Sepharose in a  Ca÷÷-dependent manner, 
this observation demonstrates that striatin directly binds 
Ca +  ÷-calmodulin. 
Striatin Is Not Directly Involved in cAMP Synthesis 
Since striatin was discovered in synaptosomal adenylyl cy- 
clase-enriched fractions, various  studies  have  been  per- 
formed to establish whether or not this protein is involved 
in cAMP production, by itself or by interacting with ade- 
nylyl cyclase components. 
The bacterial full-length fusion protein expressed by plas- 
mid pFCGN is unable to restore a cya phenotype in E. coli 
cells deficient in adenylyl cyclase, whether these cells har- 
bor a plasmid encoding calmodulin or not. The bacterially 
expressed striatin  thus does not  encode an  adenylyl cy- 
clase able to function in E. coli. 
Pellets of immunoprecipitated brain striatin do not con- 
tain  any measurable  adenylyl cyclase activity. Brain FC 
fractions highly enriched in adenylyl cyclase activity, when 
preincubated with affinity-purified anti-peptide  I  and II 
antibodies in large excess, display the same adenylyl cy- 
clase activities as do control fractions (not shown). Like- 
wise, FC fractions complemented with various amounts of 
bacterially expressed striatin (contained in CaM-Sepharose 
EDTA eluates, as described) have the same adenylyl cy- 
clase activities as control fractions. 
We have compared the cAMP contents of COS-1  cells 
overexpressing striatin  (pFSVL-transfected cells)  and  of 
control cells, according to the procedure described by Salo- 
mon (39). Various assay conditions were tested: basal con- 
ditions  (cells  unchallenged  with  adenylyl  cyclase  effec- 
tors), stimulatory conditions (addition of 10 IxM forskolin, 
with  or without  1 p~M isoproterenol, to the  culture me- 
dium),  and assays in  the presence of various concentra- 
tions of the Ca ++ ionophore A  23187. No meaningful dif- 
ferences in the cAMP contents of control and transfected 
cells could be detected (not shown). We conclude that the 
overexpressed striatin does not grossly modify the cAMP 
synthesis machinery of COS cells. In those cells, however, 
the type(s) of adenylyl cyclase expressed is not known, and 
it is conceivable that striatin, in case it affects the function 
of adenylyl cyclase, operates in the context of one particu- 
lar type of adenylyl cyclase. 
Striatin Is Mostly Expressed in the Central 
Nervous System 
RNA  analysis  by  Northern  blots  using  four  different 
probes, which together span the whole striatin coding se- 
quence, show that among all tested rat or mouse tissues, 
striatin is expressed almost exclusively in the central ner- 
vous system (Fig. 4 A, lanes 1, 2, 3, and 11). Four rat tran- 
scripts  of  8.3,  7.7,  5.5,  and  4.7  kb  are  detected.  Their 
lengths greatly exceed that of the striatin  ORF (2.3 kb); 
however, brain messenger RNAs are known to have un- 
usually long 3' UTRs (43). The 8.3- and 5.5-kb transcripts 
are most abundant in brain and cerebellum (Fig. 4, lanes 1 
and 2), the 4.7 transcript is the major species in the spinal 
cord (Fig. 4, lane 3). Blots exposed for longer times reveal 
all four transcripts in testes (not shown). In Northern blots 
of mouse brain revealed with rat probes, only two tran- 
scripts of 8.3 and 5.5 kb are readily detected (Fig. 4 A, lane 
11). Only two of the four transcripts encode the full-length 
protein,  as  shown  in  Northern  blots  hybridized with  a 
probe corresponding to the 5'  region (probe 1; Fig. 2 B, 
double-headed arrow). 
To know  whether  the  four transcripts  originate  from 
one or several homologous genes, rat genomic Southern 
blots have been probed with a DNA probe revealing the 
four transcripts. They yield a simple pattern, only one frag- 
ment being present in the DNA digested with BamHI or Pstl 
(Fig. 4 C, lanes 1 and 4) and two with EcoRI (Fig. 4 C, lane 2), 
as expected if the four transcripts originate from one gene. 
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from different rat and mouse tissues (5 Ixg RNA per lane). Stria- 
tin is almost only expressed in the CNS. (A) A  probe spanning 
striatin  sequence  668-1,647 reveals  four  transcripts  in  rat  CNS 
(brain, cerebellum, and spinal  cord;  lanes 1, 2, and 3) and two 
transcripts  in mouse brain (lane 11). In the encart below, a 13-ac- 
tin probe was applied to the same blot. (B) Probe 1 spanning stri- 
atin sequence  1-750 reveals only two transcripts in rat and mouse 
brain (Fig. 4 B, lanes 1 and 3) and one of 5.5 kb in the rat spinal 
cord.  C  is  a  Southern  blot  of rat  genomic  DNA  digested  by 
BamHI (lane 1), EcoRI (lane 2), HindlII (lane 3), and PstI (lane 4), 
probed with DNA fragment 1293-2316 (containing an EcoRI site). 
The multiplicity of transcripts therefore probably reflects 
alternative splicing or the existence of several promotors. 
In situ  hybridization  studies  using two  sets  of probes, 
one spanning the 5' region of striatin (first 750 bp) and the 
other  spanning  the  central  region,  show  that  striatin  is 
mainly found and intensely expressed in the dorsal stria- 
tum and the olfactory tubercle (Fig. 5, A  and C). The nu- 
cleus accumbens (ventral striatum) is scarcely labeled. A 
significant level of striatin mRNA is detected in the cere- 
bral cortex, hippocampus, olfactory bulb, cerebellum (Fig. 5, 
A  and  C)  and  spinal cord grey matter (not shown).  The 
control, sense, probes give no signal except in the hippo- 
campus and more intensely in the cerebellum, as it is often 
the case for these two densely populated structures (Fig. 5, 
B and D). 
Striatin Is Essentially Localized in Striatal 
Dendritic Spines 
The localization of striatin in different regions of the brain, 
as studied by Western blots, parallels the distribution of its 
mRNA; the highest amount of immunoreactive material is 
found in striatal homogenates (Fig. 3 D, lane 4). Striatin is 
present but less abundant in cortex, hippocampus, and cer- 
ebellum (~10 times less per mg protein; Fig. 3, lanes 2, 3, 
and 5), and scarce in the hypothalamus (Fig. 3, lane 1). 
Immunocytochemical labeling of brain sections using af- 
finity-purified antibodies directed against peptides II and 
III reveals that striatin is found in the striatum, where the 
perikarya of most neurons are labeled, as well as many ele- 
ments of the neuropil (Fig. 6, A  and B). Other structures 
that build up the motor system, i.e., the pyramidal neurons 
from  layer  V  in  the  sensory-motor cortex,  brain  nuclei 
such as the red nucleus (to be shown elsewhere) as well as 
the  cerebellum,  in  the  molecular layer, are  also  labeled 
(Fig. 6 D). In spinal cord sections, striatin is seen in moto- 
neurons, in cell bodies and dendrites  (Fig. 6  E).  Similar 
results have been obtained with the two sets of antibodies 
directed against different epitopes of striatin. Sections treated 
with  antibodies preincubated  with an excess of the  rele- 
vant peptide do not show reaction product (Fig. 6 C). 
At the ultrastructural level in the striatum, the vast ma- 
jority  of  neurons  are  stained.  These  neurons  have  a 
rounded nucleus and all the morphological characteristics 
of medium spiny,  GABAergic  neurons.  The  subcellular 
structures that contain the highest amount of DAB reac- 
tion product are dendritic spines (Fig. 7, A, C, and D); la- 
beled dendritic  shafts are  sometimes seen  (Fig.  7  B).  In 
conditions that limit the dispersion of the reaction product 
away from its origin, the immunolabeling is mostly local- 
ized in the vicinity of the postsynaptic density and of the 
postsynaptic membrane  (Fig.  7  D).  Dendrites  are,  how- 
ever, labeled all along their course, whereas axons are un- 
labeled. In neuronal cell bodies, a discrete labeling occurs 
in the cytoplasm around the nucleus, but not in the nucleus 
itself or in the lumen of the rough ER or of the Golgi ap- 
paratus (not shown). Sections treated with antibodies pre- 
incubated  with  an excess of the  relevant peptide  do  not 
show any reaction product (Fig. 7 E). 
Discussion 
Striatin,  a  novel  protein  found  in  the  CNS,  has  several 
characteristics,  suggesting a  possible role in  postsynaptic 
signaling.  First,  it directly binds CaM in  the presence of 
Ca  ++ ,  as  demonstrated  by  the  study  of  bacterially  ex- 
pressed  striatin.  Secondly,  its  sequence  contains  eight 
WD-repeats  in  its  COOH-terminal  part.  The  family  of 
WD-repeat proteins is characterized by the presence of a 
series of four to eight conserved repeating units of 23-41 
amino acids, usually beginning with GH and ending with 
WD, separated by short, variable sequences (29). To our 
knowledge, striatin is the first known WD-repeat protein 
that binds Ca++-CaM. Up to now, all known proteins be- 
longing to this family are eukaryotic regulatory proteins, 
none so far being an enzyme. Some interact with compo- 
nents of the cytoskeleton, like coronin (11), or of vesicles, 
like  Secl  3p  (33),  or participate  in  supramolecular com- 
plexes involved in transcription or translation processes. A 
number of them, among which  are the [3 subunits  of het- 
erotrimeric G  proteins, play a role in signal transduction. 
Striatin  is  not  a  member  of  already  known  WD-repeat 
subfamilies, since its WD-repeats are not similar to theirs 
in equivalent positions. In particular, it is not a member of the 
Castets et al. Striatin, A Postsynaptic, Calmodulin-binding  WD-Repeat Protein  1057 Figure 5.  Striatin is predominantly  expressed in the striatum. Dark-field autoradiograms of rat brain sagittal (A and B) and coronal (C 
and D) sections. In situ hybridization  with the antisense RNA probe (A and C) shows an intense and specific labeling in the striatum (st; 
A and C) and the olfactory tubercle (ot; A  and C) and a moderate staining of the nucleus accumbens (a; C) and cortex (cx; A  and C), as 
compared to the sense labeling (C and D). The positive hybridization signal in the hippocampus (h; A) detected with the antisense 
probe is significantly  stronger than the weak staining seen with the sense probe (B); the signals given by both probes are comparable for 
the cerebellum (cer; A  and B). 
The Journal  of Cell Biology,  Volume 134, 1996  1058 Figure 6.  Striatin is present in the CNS motor system.  Immunocytochemical localization at the light microscope. Immunolabeling ob- 
tained with the affinity-purified anti-peptide III antibody. (A-C) Coronal sections of the striatum. (A) Low concentration of antibody 
(1 p~g/ml). The striatum (str) is more labeled than the cortex (cx). No labeling is observed in the corpus callosum (cc). (B) Higher con- 
centration of antibody (3 p.g/ml). The perikarya of most striatal neurons are labeled, but not the nuclei. The neuropil is strongly labeled. 
(C) Adjacent section treated with the antibody preadsorbed with peptide III. (D) Coronal section of the cerebellum. The molecular 
layer (ml) is densely stained, whereas no labeling is seen in the granular layer (gl). The Purkinje cell bodies (P) are lightly labeled. (E) 
Cross-section of the spinal cord, same treatment as in D. vh, ventral horn. The motoneurons are stained at the level of the cell bodies 
and dendrites, whereas their axons (arrows) are not. Bars, 100 p~m (10 jxm in B). 
13 subunits  of heterotrimeric  G  proteins.  The WD-repeat 
domains of rat striatin and human SG2NA (29) are, on the 
contrary, conserved. Although radically differing in their 
subcellular  localizations,  and  therefore  probably  in  their 
functions, striatin and SG2NA thus constitute a novel sub- 
family of WD-repeat proteins. 
The peptides whose sequences allowed us to clone stria- 
tin originated from a Lubrol-soluble synaptosomal protein 
thought  to be  membrane  bound  (6).  The  study  of brain 
subcellular fractions with antibodies directed against stria- 
tin peptides and a fusion protein confirmed that striatin  is 
almost entirely particulate  and that most of it can be solu- 
bilized by Lubrol. Striatin is therefore not a protein intrin- 
sic to PSDs, but appears to be associated with membranes. 
Yet, we found no sequences able to account for hydropho- 
bic et helices or consensus sequences for lipidic, posttrans- 
lational modifications, although palmitoylation is theoreti- 
cally possible.  Striatin  possesses  two  polybasic domains, 
one bearing a net positive charge of 9. They may play a role 
in the binding of striatin  to membranes, since it has been 
shown that stretches of basic amino acids mediate or at least 
help to promote protein binding to the membrane (21). 
Striatin  is  largely  expressed  in  structures  belonging  to 
the CNS motor system. In situ hybridization and immuno- 
cytochemistry show that striatum is the brain structure dis- 
playing  the  highest  content  of striatin.  The  caudate  nu- 
cleus contains significantly more striatin  than the nucleus 
accumbens.  In  Huntington-affected  striata,  the  neurons 
that undergo apoptosis are also those present in the cau- 
date nucleus, not those in the nucleus accumbens. Besides 
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striatin  is  localized  in  the 
postsynaptic  compartment 
of synapses. Electron micro- 
graphs.  Immunocytochemi- 
cal localization obtained with 
an  affinity-purified antibody 
directed  against peptide  III. 
(Similar  results  were  ob- 
tained with antibody directed 
against peptide II). (A) Low 
magnification  showing  im- 
munolabeled dendritic spines 
(arrows) and  one  unlabeled 
synapse  (star).  (B)  Higher 
magnification showing  a  la- 
beled structure that is proba- 
bly a  dendritic shaft.  In this 
experiment, both the first an- 
tibody  (3  ~tg/ml)  and  DAB 
concentrations  were  inten- 
tionally increased to obtain a 
strong  labeling.  (C)  A  la- 
beled  dendritic  spine.  (D) 
Lighter labeling obtained  at 
low  first  antibody (1  txg/ml) 
and  DAB  concentrations, 
suggesting that  striatin is lo- 
calized close to  the  postsyn- 
aptic  density  (arrowhead) 
and to the postsynaptic mem- 
brane in dendritic spines. (E) 
Absence of immunoreaction 
inside  two  dendritic  spines. 
In  this  control,  the  affinity- 
purified  antibody  directed 
against  peptide  III  was 
preadsorbed  overnight  with 
peptides Ili and II in a  100- 
fold molar excess before im- 
munolabeling. Bars, 0.2 Ixm. 
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matter, olfactory tubercle, and hippocampus also contain 
striatin messengers. Immunolabeling studies of brain and 
spinal cord sections using affinity-purified anti-striatin pep- 
tide antibodies confirm the presence of striatin in the mo- 
tor system, in particular layer V  of the sensory-motor cor- 
tex,  striatum, brain motor nuclei, cerebellum,  and spinal 
cord  grey  matter  (to  be  described  in  detail  elsewhere). 
These studies indicate that (a) only neurons contain stria- 
tin, no glial cells having been shown to contain any. (b) In 
the  labeled  neurons,  two  compartments contain striatin: 
the  cell  bodies,  with  the  exception  of nuclei,  and  more 
abundantly, the neuropil. In the cerebellum, the molecular 
layer is immunolabeled, but not the granular layer. In spi- 
nal cord  sections,  the  dendrites  of the  motoneurons are 
stained, whereas the axons are unlabeled.  Ultrastructural 
studies show that the vast majority of striatal neurons con- 
tain striatin and have the morphological characteristics of 
medium spiny neurons. Striatin is mostly confined to den- 
drites, predominantly the dendritic spines, where the reac- 
tion product is apposed to the inner face of the synaptic 
membrane and to the PSDs. Thus, in all neurons examined 
so  far,  striatin  is  present  solely  in  the  somato-dendritic 
compartment, predominantly in the dendritic spines. 
The high concentration, in dendritic spines, of compo- 
nents involved in cAMP  and Ca ++  signaling  is generally 
viewed as facilitating the reception, transmission, and inte- 
gration of signals carried by both cAMP and Ca ++ (8, 26). 
Indeed,  the postsynaptic  compartment contains channels 
such as voltage-gated ion channels and glutamate (N-methyl- 
D-aspartate  [NMDA])  receptor  channels,  regulatory  en- 
zymes, and proteins involved in transduction, such as the 
abundantly represented  calcium/CaM-dependent  protein 
kinase  type  II,  cAMP-dependent  protein  kinase,  CaM, 
CaM-dependent cAMP phosphodiesterases (23), calcium/ 
phospholipid-dependent  protein kinase C (1), calcineurin 
(17), and adenylyl cyclase (27). Although adenylyl cyclase 
is expressed in neurons in the same postsynaptic compart- 
ment as striatin, so far we have been unable to find a rela- 
tionship between striatin and the cAMP machinery. Of in- 
terest,  however, is  the fact that  striatum is  the  only one 
brain structure specifically endowed with adenylyl cyclase 
type  V  (16),  in association with Golf c~ (rather than G~a) 
(12, 19) and GI37 subunits (46). 
The direct binding of striatin to Ca++-CaM must be of 
great importance, since dendritic spines are individual cal- 
cium compartments (47). The extremely large variations in 
Ca ÷+  concentrations  that  occur  within  these  structures 
(34)  have numerous biological consequences, such as the 
local regulation of the ras and MAP kinase pathways (13) 
or of microtubules, or the mechanisms of Ca ++ buffering, 
so important with respect to Ca ++ cytotoxicity (42). Stria- 
tin is thus likely to interact, in a Ca++-dependent manner 
and  through its  WD-repeat  domain, with  one  or several 
members of the surrounding cluster of signaling or cytosk- 
eletal molecules present in dendritic spines. The as yet un- 
known function of striatin is currently being  investigated 
by the indirect, two-hybrid technique. The special distribu- 
tion of striatin within the CNS turns it into a marker for a 
defined subset of neurons, and more particularly, of their 
dendrites. As such, it might be instrumental to study stria- 
tin in the course of neurodegenerative diseases. 
We thank C. Klee for critical reading of the manuscript; Vincent Mdjean, 
Vincent G61i, and Jacques Haiech for advice; Anne-Marie Lesourd for ex- 
cellent technical assistance for immunocytochemistry; and A. Ullmann for 
generous support. 
This work was supported by grant 92.T.0348 from Minist6re de la Re- 
cherche  et  de  l'Espace  to  Celaster  Etudes  Recherches  et  Production 
(CEREP) and A. Monneron; grant 2018 from Association pour la Recher- 
che sur le Cancer; and grant 3655 from Association Fran~aise contre les My- 
opathies. A  grant from Association France Parkinson is deeply acknowl- 
edged. F.  Castets held  a  fellowship from Association Franqaise pour la 
Recherche sur le Cancer. 
Received for publication 5 December 1995 and in revised form 1 February 
1996. 
References 
1.  Akers, R.F., D.M. Lovinger, P.A. Colley, D.J. Linden, and A. Routtenberg. 
1986. Translocation of protein kinase C activity may mediate hippocam- 
pal long-term potentiation. Science (Wash. DC). 231:587-589. 
2.  Altschul, S.F,, W. Gish, W. Miller, E.W. Myers, and D.J. Lipman. 1990. Ba- 
sic local alignment search tool. J. Mol. BioL 215:403-410. 
3. Auffray, C., and F. Rougeon. 1980. Purification of mouse immunoglobulin 
heavy-chain messenger RNAs from total myeloma tumor RNA. Eur. Z 
Biochem. 107:303-314. 
4.  Birnboim, H.C~, and J. Doly. 1979. A  rapid alkaline extraction procedure 
for  screening recombinant  plasmid DNA.  Nucleic Acids  Res.  7:1513- 
1523. 
5.  Burns, M.E., and G.J. Augustine. 1995. Synaptic structure and function: dy- 
namic organization yields architectural precision. Cell. 83:187-194. 
6.  Castets, F., G. Baillat, S. Mirzoeva, K. Mabrouk, J. Garin, J. d'Alayer, and 
A. Monneron. 1994. A  brain synaptosomal adenylyl cyclase of high spe- 
cific  activity is photolabeled with  azido-ATP.  Biochemistry.  33:5063- 
5069. 
7.  Cohen, R.S., F. Blomberg, K. Berzins, and P. Siekevitz. 1977. The structure 
of postsynaptic densities isolated from  dog cerebral cortex.  I.  Overall 
morphology and protein composition. Z  Cell Biol. 74:181-203. 
8. Cooper, D.M.F.,  N.  Mons, and J.W. Karpen.  1995. Adenylyl cyclases and 
the  interaction between calcium and cAMP signalling. Nature  (Lond.). 
374:421-424. 
9.  Coussen, F., J. Haiech, J. d'Alayer, and A. Monneron. 1985. Identification 
of the catalytic subunit of brain adenylate cyclase: a calmodulin-binding 
protein of 135 kDa. Proc. Natl. Acad. Sci.  USA. 82:6736-6740. 
10. d'Alayer, J., G. Berthillier, and A. Monneron. 1983. Structure of brain ade- 
nylate  cyctase:  proteolysis-dependent  modifications.  Biochemistry.  22: 
3984-3953, 
11. de  Hostos,  E.L..  B.  Bradtke,  F.  Lottspeich,  R.  Guggenheim,  and  G. 
Gerisch. 1991. Coronin, an actin-binding protein of Dictyostelium discoi- 
deum localized to cell surface projections, has sequence similarities to G 
proteins 13 subunits. EMBO (Eur. MoL Biol. Organ.),I. 10:4097-4104. 
12. Drinnan, S.L.,  B.T. Hope~ T.P. Snutch, and S.R. Vincent~  1991. Gol  f in the 
basal ganglia. Mot. Cell Neurosci. 2:66-70. 
13. Finkbeiner, S,, and M.E. Greenberg. 1996. Ca++-dependent routes to Ras: 
mechanisms for neuronal survival, differentiation and plasticity? Neuron. 
16:233-236. 
14. Garoff,  H.,  and  W.  Ansorge.  1981.  Improvements of DNA  sequencing. 
Anal Biochem.  115:450-457. 
15. Glaser, P.,  D. Ladant, O. Sezer, F.  Pichot, A. Ullmann, and A. Danchin. 
1988. The calmodulin-sensitive adenylate cyclase of Bordetella pertussis: 
cloning and expression in Escherichia coli. Mol. Microbiol. 2:19-30. 
16. Glatt, C.E., and S.H. Snyder. 1993. Cloning and expression of an adenylyl 
cyclase localized to the corpus striatum. Nature (Loud.). 361:536-538. 
17. Goto. S.. Y. Matsukado. E. Miyamoto, and M. Yamada, 1987. Morphologi- 
cal characterization of the rat striatal neurons expressing calcineurin im- 
munoreactivity. Neuroscience. 22:189-201. 
18. Hedegaard, L., and A. Danchin. 1985. The cya gene region ofErwina chry- 
santhemi B 374: organisation and gene products. MoL & Gen. Genet~ 201: 
38-42. 
19. Herv& D.,  M.  L6vi-Strauss, I.  Marey-Semper, C. Verney, J-P.  Tassin, J. 
Glowinski, and J-A. Girault. 1993. Gol  f and G~ in rat basal ganglia: possi- 
ble involvement of Gol  f in the coupling of dopamine D1  receptor with 
adenylyl cyclase. Z  Neurosci. 13:2237-2248. 
20.  Kennedy, M.B.  1993. The postsynaptic density. Curr.  Opin.  NeurobioL 3: 
732-737. 
21, Kim, J., M. Mosior, L,A. Chung, H. Wu, and S. McLaughlin. 1991. Binding 
of peptides with basic residues to membranes containing acidic phospho- 
lipids.  Biophys. J. 60:135-148. 
22.  Kozak, M. 1986, Point mutations define a sequence flanking the AUG initi- 
ator codon that modulates translation by eukaryotic ribosomes. Cell. 44: 
283-292. 
23.  Ludvig, N., V. Burmeister, P.C. Jobe, and R.L. Kincaid. 1991. Electron mi- 
Castets et al. Striatin, A Postsynaptic, Calmodulin-binding WD-Repeat Protein  1061 croscopic immunocytochemical evidence that the calmodulin-dependent 
cyclic nudeotide phosphodiesterase is localized predominantly at post- 
synaptic sites in the rat brain. Neuroscience. 44:491-500. 
24.  Mendel-Hartvig, I. 1982.  A  simple and rapid method for the isolation of 
peptides from  sodium dodecyl sulfate-containing polyacrylamide gels. 
Anal Biochem.  121:215-217. 
25. Monneron,  A.,  and J.  d'Alayer.  1980.  Effects of cross-linking agents on 
adenylate cyclase regulation. FEBS Lett. 109:75-80. 
26.  Mons,  N., and D.M.F.  Cooper.  1995.  Adenylate cyclases: critical loci in 
neuronal signaling. Trends Neurosci. 18:536-542. 
27.  Mons, N., A. Harry, P,  Dubourg, R.T.  Premont, R. Iyengar, and D.M.F. 
Cooper.  1995.  Immunohistochemical localization of adenylyl cyclase in 
rat brain indicates a  highly selective concentration  at synapses. Proc. 
Natl. Acad. Sci. USA. 92:8473-8477. 
28. Muro, Y., E.K.L. Chan, G. Landberg, and E.M. Tan. 1995. A cell-cycle nu- 
clear autoantigen containing WD-40 motifs expressed mainly in S and G2 
phase cells. Biochem. Biophys. Res. Commun. 207:1029-1037. 
29. Neer, E.J., C.J. Sehmidt, R. Nambudripad, and T.F. Smith. 1994. The an- 
cient regulatory-protein family of WD-repeat proteins. Nature (Lond.). 
371:297-300. 
30.  Neville, D.M.  1971.  Molecular weight determination of protein-dodecyl 
sulfate complexes by gel electrophoresis in a  discontinuous buffer sys- 
tem. Z  Biol. Chem. 246:6328-6334. 
31.  Orlando. C., J. d'Alayer, G. Baillat, F. Castets, O. Jeannequin, J-C. Mazie, 
and A. Monneron. 1992. A monoclonal antibody directed against the cat- 
alytic site of Bacillus anthracis adenylyl cyclase identifies a novel mam- 
malian brain catalytic subunit. Biochemistry. 31:3215-3222. 
32. Penin,  F.,  C.  Godinot,  and D.C.  Gautheron.  1984.  Two-dimensional gel 
electrophoresis of membrane proteins using anionic and cationic deter- 
gents. Application to the study of mitochondrial F0-FI-ATPase. Biochim. 
Biophys. Acta. 775:239-245. 
33.  Pryer, N.K., N.R. Salama, R. Schekman, and C.A. Kaiser. 1993. Cytosolic 
Secl3p complex is required for vesicle formation from the endoplasmic 
reticulum in vitro. ,L Cell Biol. 120:865-875. 
34.  Regher, W.G., and D.W. Tank.  1994.  Dendritic calcium dynamics. Curr. 
Opin. NeurobioL 4:373-382. 
35.  Remaut, E., P. Stanssens, and W. Fiers. 1981. Plasmid vectors for high-effi- 
ciency expression controlled by the PL promotor of coliphage lambda. 
Gene (Amst.). 15:81-93. 
36.  Rose, J.K., L. Buonocore, and M.A. Whitt. 1991. A  new cationic liposome 
reagent mediating nearly quantitative transfection of animal cells. Bio- 
techniques. 10:520-525. 
37. Rychlik, W., and R.E. Rhoads. 1989. A computer program for choosing op- 
timal oligonucleotides for filter hybridization, sequencing and  in  vitro 
amplification of DNA. Nucleic. Acids Res. 17:8543--8551. 
38.  Salin, P., and M.F. Chesselet. 1993. Expression of GAD (Mr 67,000) and its 
messenger RNA in basal ganglia and cerebral cortex after ischemic corti- 
cal lesions in rats. Exp. Neurol. 119:291-301. 
39.  Salomon, Y. 1991. Cellular responsiveness to hormones and neurotransmit- 
ters: conversion to  [3HI adenine to [3HI cAMP in cell monolayers, cell 
suspensions, and tissue slices. In Methods in Enzymology. R.A. Johnson 
and J.D. Corbin, editors. Academic Press, San Diego, CA. 195:22-28. 
40.  Sambrook, J., E.F. Fritsch, and T. Maniatis. 1989.  Molecular Cloning: A 
Laboratory Manual. 2nd edition. Cold Spring Harbor Laboratory, Cold 
Spring Harbor, NY. 545 pp. 
41.  Schaffner,  W.,  and C.  Weissmann.  1973.  A  rapid, sensitive and specific 
method for the determination of protein dilute solution. Anal, Biochem. 
56:502-514. 
42.  Segal, M. 1995. Dendritic spines for neuroprotection: a hypothesis. Trends 
Neurosci. 18:468-470. 
43. Sutcliffe, J.G.  1988.  mRNA  in  the  mammalian central  nervous system. 
Annu. Rev. NeuroscL 11:157-198. 
44. Trimble, W.S., M. Linial, and R.H. Scheller. 1991. Cellular and molecular 
biology of the presynaptic nerve terminal. Annu. Rev. Neurosci. 14:93-122. 
45. Van Regenmortel, M.H.V., J-P. Briand, S. Muller, and S. Plaur. 1988. Syn- 
thetic Polypeptides As Antigens. Laboratory Techniques in Biochemis- 
try and Molecular Biology. Vol. 19. R.H. Burdon and P.H. Van Knippen- 
berg, editors. ElsevierfNorth Holland, Amsterdam. 95-130. 
46.  Watson, J.B., P.M. Coulter II, J.E. Margulies, L. de Lecea, P.E. Danielson, 
M.G.  Erlander, and J.G.  Sutcliffe. 1994.  G-protein ~,7 subunit is selec- 
tively expressed in medium-sized neurons and dendrites of the rat neo- 
striatum. J. Neurosci. Res. 39:108-116. 
47.  Yuste, R., and W. Denk. 1995. Dendritic spines as basic functional units of 
neuronal integration. Nature (Lond.). 375:682-684. 
The Journal of Cell Biology, Volume 134, 1996  t062 